Cystic fibrosis patients in Saskatchewan aged six and older who meet specific medical criteria now have access to a new drug called Alyftrek, according to an announcement by the Saskatchewan Ministry of Health. The treatment works for patients with one of 266 specific genetic mutations that cause the disease, which damages both the lungs and the digestive system.
Alyftrek Availability and Regulatory Timeline
The provincial coverage follows a recommendation issued by Health Canada in July 2025, according to the Ministry of Health. Following that recommendation, pricing negotiations took place last month, leading to the current public coverage decision for eligible residents.
“Our government is pleased to cover the cost of this new treatment for Saskatchewan patients with cystic fibrosis,” Saskatchewan Health Minister Jeremy Cockrill said in a statement provided by the ministry. He added that the therapy has been shown to improve quality of life and helps patients lead healthier lives.
Impact on Saskatchewan’s CF Community
Cystic fibrosis remains a serious genetic condition affecting thousands of Canadians. According to provincial data, more than 4,500 people live with cystic fibrosis across Canada, with nearly 150 of those individuals residing in Saskatchewan.
Did you know? Alyftrek is effective specifically for patients carrying one of 266 distinct genetic mutations responsible for cystic fibrosis symptoms and disease progression.
Patients diagnosed with cystic fibrosis, as well as parents of children managing the condition, are encouraged by the ministry to consult their doctor to determine if they qualify for the newly covered treatment.
Frequently Asked Questions
Who is eligible for Alyftrek coverage in Saskatchewan?
According to the Saskatchewan Ministry of Health, the drug is available to cystic fibrosis patients aged six and older who meet established medical criteria and possess one of 266 eligible genetic mutations.
What regulatory steps preceded provincial coverage?
Health Canada recommended the drug in July 2025, which was followed by pricing negotiations that concluded last month before the ministry announced public coverage.
How many people live with cystic fibrosis in Saskatchewan?
The Ministry of Health reports that nearly 150 people live with cystic fibrosis in Saskatchewan, part of a broader Canadian population of more than 4,500 individuals.
Have questions about accessing new treatments or want to stay updated on provincial health policy changes? Subscribe to our newsletter or leave a comment below to join the discussion.